English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Press release submission
| May 17, 2019
NORTHWESTERN MEMORIAL HOSPITAL: Annual Minds Matter Benefit Dinner Raises Funds for Northwestern Medicine Brain Tumor Patients
Press release submission
| May 10, 2019
EISAI INC.: Lower Hospitalization Rates In Epilepsy Patients Treated With Adjunctive FYCOMPA® (perampanel) CIII
Press release submission
| May 9, 2019
HOSPITAL FOR SPECIAL SURGERY: HSS Researchers Advance Understandings of the Cellular Mechanisms Driving Rheumatoid Arthritis
Press release submission
| May 2, 2019
AMERICAN ACADEMY OF NEUROLOGY: Cannabis-based Medicine May Reduce Seizures for Children with Difficult-to-Treat Epilepsy
Press release submission
| May 1, 2019
LEANMD, INC.: Looks to End the Obesity Epidemic One Person at a Time
Press release submission
| Apr 25, 2019
PROVENTION BIO, INC.: Completes Enrollment of Phase 2a PRINCE Clinical Trial with PRV-6527 in Patients with Moderate to Severe Crohn's Disease
Press release submission
| Apr 23, 2019
ELI LILLY AND COMPANY: Lilly Announces Positive Top-Line Results for COAST-X, a 52-Week Placebo-Controlled Study of Taltz® (ixekizumab) in Patients with Non-Radiographic Axial Spondyloarthritis
Press release submission
| Apr 19, 2019
TELA BIO, INC.: Announces 510(k) Clearance for Restella™ Reconstructive BioScaffolds for Reconstructive Surgery
Trending
+
Pharmaceuticals
Patient Daily
| Oct 30, 2025
Baylor St. Luke's receives GammaTile Center of Excellence designation for brain tumor care
+
Pharmaceuticals
Patient Daily
| Oct 29, 2025
Paragon Health Institute senior fellow: 340B program 'needs real reform'
+
Pharmaceuticals
Patient Daily
| Nov 3, 2025
Patient groups urge Congress to renew enhanced premium tax credits before open enrollment
+
Pharmaceuticals
Patient Daily
| Oct 30, 2025
Study links higher death rates in veterans’ post-TBI epilepsy
« First
«
…
18
19
20
21
22
23
24
…
»
Last »